Common Drugs Used to Treat Behavior Problems in Dogs

Common Drugs Used to Treat Behavior Problems in Dogs

Drug (Class)

Dosage

Indications

Adverse Effects

Fluoxetine (SSRI)

1–2 mg/kg, PO, q 24 ha,b,c,d

FDA approved for canine separation anxiety.

Extralabel indications include anxiety disorders, phobias, conflict aggression, fear aggression, compulsive disorders, excessive arousal, impulsivity, and urine marking.b,d,e

Anorexia, hyporexia, lethargy, sedation, vomiting, diarrhea, restlessness, vocalization, agitation, tremors, seizures, changes in urine frequency. Aggression has also been reported.

In humans, hyponatremia, changes in glucose, bleeding, and hepatotoxicosis have been reported.

Paroxetine (SSRI)

1–2 mg/kg, PO, q 24 hb,d,e

Anxiety disorders, phobias, conflict aggression, fear aggression, compulsive disorders, excessive arousal, impulsivity, and urine marking.b,d,e

Extralabel.

Lethargy, salivation, hyporexia, anorexia, vomiting, diarrhea, anxiety, irritability, aggression, insomnia, hyponatremia, mydriasis, hyperactivity or panting, constipation, urinary retention, cardiac arrhythmias. Less likely than fluoxetine to cause anorexia.

In humans, abnormal bleeding and hepatotoxicosis have been reported.

Sertraline (SSRI)

0.5–4 mg/kg, PO, q 24 hb,c,d,e

Anxiety disorders, phobias, conflict aggression, fear aggression, compulsive disorders, excessive arousal, impulsivity, and urine marking.b,d,e

Extralabel.

Anorexia, hyporexia, sedation, lethargy, vomiting, diarrhea, changes in urine frequency, excitement, anxiety, agitation, seizures.

In humans, abnormal bleeding and hepatotoxicosis have been reported.

Clomipramine (TCA)

Label dose: 2–4 mg/kg, PO, q 24 h, or 1–2 mg/kg, PO, q 12 h

Extralabel dose: 1–4 mg/kg, PO, q 12–24 he,f

FDA approved for canine separation anxiety.

Extralabel indications include anxiety disorders, phobias, conflict aggression, fear aggression, compulsive disorders, excessive arousal, impulsivity, and urine marking.b,d,e

Anorexia, hyporexia, vomiting, diarrhea, dry mouth, sedation, lethargy, depression, decreased total thyroxine and free thyroxine in euthyroid dogs, mydriasis, changes in liver enzymes, seizures.b,e

Buspirone (azapirone)

0.5–2 mg/kg, PO, q 8–12 hc,e

Anxiety and fearfulness.b,c,d,e

Extralabel.

Vomiting, diarrhea, nausea, agitation, behavioral disinhibition, bradycardia, stereotypical behaviors.d,e

Trazodone (serotonin antagonist and reuptake inhibitor)

2–7.5 mg/kg, PO, q 8–24 h as needed, up to 19.5 mg/kg in any 24-h periode,g

Anxiety disorders, fear aggression, compulsive disorders, sedation/anxiolysis for veterinary care, postsurgical confinement.d,e,g,h,i

Extralabel.

Nausea, vomiting, diarrhea, sedation, ataxia, agitation, restlessness, increased anxiety, aggression, tachycardia. Hepatotoxicosis and priapism have also been reported.d,e

Clonidine (alpha-2-adrenergic agonist)

0.01–0.05 mg/kg, PO, q 8 h as needed, or q 8–12 h when administered regularlyc,d,e

Anxiety, fear, phobias, panic, neuropathic pain.d,e

Extralabel.

Sedation, hypotension, nausea, dry mouth, ataxia, sleep disturbances, excitement, urinary incontinence, bradycardia, hypotension, collapse.

Dexmedetomidine oral gel (alpha-2-adrenergic agonist)

125 mcg/m2 (not mg/kg), oral transmucosal, q 2 h as needed for maximum 5 doses during one noise eventj

FDA approved for canine noise aversion.

Extralabel indications include other fear, anxiety (eg, fear of car rides, fear of veterinary care).d,j

Sedation, vomiting, gastroenteritis, drowsiness, inappropriate urination.j,k

Gabapentin (gabapentinoid, or alpha-2-delta ligand)

5–30 mg/kg, PO, q 8 h when administered regularly, or 20–50 mg/kg, PO, 90 minutes before stressor as neededc,d,e

Anxiety, fear, neuropathic pain, seizures.d,e

Extralabel.

Sedation, ataxia, vomiting, diarrhea, increased appetite, agitation, excitement.

Alprazolam (benzodiazepine)

0.02–0.1 mg/kg, PO,q 6 h as neededb,e

Anxiety, fear, phobias, seizures.d,e

Extralabel.

Sedation, increased appetite, ataxia, muscle relaxation, anxiety, paradoxical excitation. Aggression has also been reported.

Diazepam (benzodiazepine)

0.5–2 mg/kg, PO, q 8 h as neededd,e

Anxiety, fear, phobias, seizures, appetite stimulant, muscle relaxant.d,e

Extralabel.

Sedation, increased appetite, ataxia, muscle relaxation, anxiety, paradoxical excitation. Aggression has also been reported.

Abbreviations: SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.

aReconcile (fluoxetine hydrochloride). PRN Pharmacal. Revised July 2021. Accessed September 3, 2025.

bCrowell-Davis SL, Murray TF, de Souza Dantas LM. Veterinary Psychopharmacology. 2nd ed. John Wiley & Sons; 2019.

cDantas LMS, Ogata N. Veterinary psychopharmacologyVet Clin North Am Small Anim Pract. 2024;54(1):195-205. doi:10.1016/j.cvsm.2023.07.003

dDenenberg S, ed. Small Animal Veterinary Psychiatry. CABI; 2020.

eBudde JA, McCluskey DM, eds. Plumb's Veterinary Drug Handbook. 10th ed. John Wiley & Sons; 2023.

fClomicalm (clomipramine hydrochloride). Virbac Corporation; 2024. Accessed September 3, 2025.

gGruen ME, Sherman BL. Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995–2007). J Am Vet Med Assoc. 2008;233(12):1902-1907. doi:10.2460/javma.233.12.1902

hKim S-A, Borchardt MR, Lee K, Stelow EA, Bain MJ. Effects of trazodone on behavioral and physiological signs of stress in dogs during veterinary visits: a randomized double-blind placebo-controlled crossover clinical trialJ Am Vet Med Assoc. 2022;260(8):876-883. doi:10.2460/javma.20.10.0547

iJokela F. Reduction of repetitive tail chasing in a mixed breed dog using multimodal therapyJ Vet Behav. 2025;78:106-112. doi:10.1016/j.jveb.2025.03.001

jSileo (dexmedetomidine oromucosal gel). Orion Pharma. Revised November 2017. Accessed September 3, 2025.

kStahl SM. Essential Psychopharmacology: The Prescriber's Guide. Cambridge University Press; 2005.

Abbreviations: SSRI, selective serotonin reuptake inhibitor; TCA, tricyclic antidepressant.

aReconcile (fluoxetine hydrochloride). PRN Pharmacal. Revised July 2021. Accessed September 3, 2025.

bCrowell-Davis SL, Murray TF, de Souza Dantas LM. Veterinary Psychopharmacology. 2nd ed. John Wiley & Sons; 2019.

cDantas LMS, Ogata N. Veterinary psychopharmacologyVet Clin North Am Small Anim Pract. 2024;54(1):195-205. doi:10.1016/j.cvsm.2023.07.003

dDenenberg S, ed. Small Animal Veterinary Psychiatry. CABI; 2020.

eBudde JA, McCluskey DM, eds. Plumb's Veterinary Drug Handbook. 10th ed. John Wiley & Sons; 2023.

fClomicalm (clomipramine hydrochloride). Virbac Corporation; 2024. Accessed September 3, 2025.

gGruen ME, Sherman BL. Use of trazodone as an adjunctive agent in the treatment of canine anxiety disorders: 56 cases (1995–2007). J Am Vet Med Assoc. 2008;233(12):1902-1907. doi:10.2460/javma.233.12.1902

hKim S-A, Borchardt MR, Lee K, Stelow EA, Bain MJ. Effects of trazodone on behavioral and physiological signs of stress in dogs during veterinary visits: a randomized double-blind placebo-controlled crossover clinical trialJ Am Vet Med Assoc. 2022;260(8):876-883. doi:10.2460/javma.20.10.0547

iJokela F. Reduction of repetitive tail chasing in a mixed breed dog using multimodal therapyJ Vet Behav. 2025;78:106-112. doi:10.1016/j.jveb.2025.03.001

jSileo (dexmedetomidine oromucosal gel). Orion Pharma. Revised November 2017. Accessed September 3, 2025.

kStahl SM. Essential Psychopharmacology: The Prescriber's Guide. Cambridge University Press; 2005.